Evaluation of Chronic Opioid Receptor Antagonist Effects Upon Weight and Intake Measures in Lean and Obese Zucker Rats
- 31 December 1997
- Vol. 18 (8) , 1201-1207
- https://doi.org/10.1016/s0196-9781(97)00074-0
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in ratsBrain Research, 1995
- Galanin in the hypothalamus of fed and fasted lean and obese Zucker ratsBrain Research, 1993
- Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in ratsBrain Research, 1992
- Ingestive behavior following central [D-Ala2, Leu5, Cys6]-Enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptorPharmacology Biochemistry and Behavior, 1991
- Reduction by central ß-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditionsBrain Research, 1990
- Suppression of nocturnal, palatable and glucoprivic intake in rats by the κ opioid antagonist, nor-binaltorphamineBrain Research, 1990
- Hypothalamic neuropeptide Y (NPY) in obese Zucker rats: Implications in feeding and sexual behaviorsPhysiology & Behavior, 1990
- Effects of β-chlornaltrexamine on food intake, body weight and opioid-induced feedingLife Sciences, 1987
- The Zucker rat: Absent circadian corticosterone periodicity and elevated β-endorphin concentrations in brain and neurointermediate pituitaryNeuropeptides, 1981
- Suppression of food intake and body weight gain by naloxone in ratsLife Sciences, 1979